The big news today is that a Chinese company has lobbed a lucrative takeover bid at Bellamy’s. We look at the implications that the Bellamy’s takeover has for other ASX-listed infant formula companies...
At time of writing, the share price of Bubs Australia Ltd [ASX:BUB] is up a significant 6.69%, trading at $1.435. After languishing for a sustained period, the Bubs share price began its take-off in February...
The share price of A2 Milk Company Ltd [ASX:A2M] rose 8% today, following an upgraded rating by UBS Wealth Management. They set a price target of $16.68.
Bubs Australia Ltd [ASX:BUB] is today the beneficiary of positive investor sentiment after the announcement of a strategic channel partnership between Bubs and Kidswant, a prominent baby retail chain in China.
Today, Bubs Australia Limited [ASX:BUB] announced it would be entering into a supply agreement with Fonterra Australia, to produce Bubs’ new organic infant formula range. At time of writing, Bubs share price is trading 12% higher at $1.48.
The company has just released its quarterly activities report, which highlighted strong revenue growth and massive sales growth in China over the last year.
The latest news out of Bubs is that it has entered a non-binding memorandum of understanding (MoU) with Chinese company Beingmate to distribute and promote its products.
Shares of Bubs Australia Ltd [ASX:BUB] have increased by almost 10% yesterday, following the news of a merchant service agreement with Alibaba, the largest e-commerce platform in China and a new manufacturer.